Skip to main content
. 2023 Jun 12;16:2393–2403. doi: 10.2147/IJGM.S408706

Table 3.

Associations Between Anosmia/Dysgeusia and Patient Characteristics

Demographic Character Description Loss of Smell n (%) No Loss of Smell n (%) P value Odds Ratio (95% CI) Loss of Taste n (%) No Loss of Taste n (%) P value Odds Ratio (95% CI)
Sex Male 92/217 (42.4%) 125/217 (57.6%) <0.001 0.5 (0.3–0.7) 89/217 (41.0%) 128/217 (59.0%) 0.002 0.5 (0.4–0.8)
Female 109/180 (60.6%) 71/180 (39.4%) 102/180 (56.7%) 78/180 (43.3%)
Nationality Bahraini 146/264 (55.3%) 118/264 (44.7%) 0.001 N/A 139/264 (52.7%) 125/264 (47.3%) 0.002 N/A
GCC 4/5 (80.0%) 1/5 (20.0%) 5/5 (100.0%) 0/5 (0.0%)
Non GCC Arab 9/11 (81.8%) 2/11 (18.2%) 7/11 (63.6%) 4/11 (36.4%)
East Asia 6/13 (35.3%) 7/13 (53.8) 5/13 (38.5%) 8/13 (61.5%)
South Asia 36/102 (35.3%) 66/102 (64.7%) 35/102 (34.3%) 67/102 (65.7%)
Other 0/2 (0.0%) 2/2 (100.0%) 0/2 (0.0%) 2/2 (100.0%)
Marital status Single 42/77 (54.5%) 35/77 (45.5%) 0.908 39/77 (50.6%) 38/77 (49.4%) 0.970
Married 154/309 (49.8%) 155/309 (50.2%) 147/309 (47.6%) 162/309 (52.4%)
Divorced 4/8 (50.0%) 4/8 (50.0%) 4/8 (50.0%) 4/8 (50.0%)
Widowed 1/2 (50.0%) 1/2 (50.0%) 1/2 (50.0%) 1/2 (50.0%)
Smoking status Smoker 41/ 76 (53.9%) 35/76 (46.1%) 0.553 0.8 (1.4–0.5) 41/76 (53.9%) 35/76 (46.1%) 0.298 0.8 (0.5–1.3)
Non smoker 158/315 (50.2%) 157/315 (49.8%) 149/315 (47.3%) 166/315 (52.7%)
Vaccination status Pfizer 19/201 (9.5%) 22/196 (5.5%) 0.647 NA 20/397 (5.0%) 21/397 (5.3%) 0.160
Sinopharm 65/118 (55.1%) 53/118 (44.9%) 65/118 (55.1%) 53/118 (44.9%)
Sputnik 19/40 (47.5%) 21/40 (52.5%) 17/40 (42.5%) 23/40 (57.5%)
COVISHILD 4/9 (44.4%) 5/9 (55.6%) 5/9 (55.5%) 4/9 (44.4%)
No vaccine 89/174 (51.1%) 85/174 (48.9%) 81/174 (46.6%) 93/174 (53.4%)
No record 5/15 (33.3%) 10/15 (66.7%) 3/15 (20%) 12/15 (80%)
Medical history Sinusitis/ allergy 12/28 (42.9%) 16/28 (57.1%) 0.590 0.8 (0.4–1.8) 12/28 (42.9%) 16/28 (57.1%) 0.921 1.0 (0.4–2.2)
Asthma / COPD 9/14 (64.3%) 4/14 (35.7%) 0.173 2.3 (0.7–7.4) 8/14 (57.1%) 5/14 (35.7%) 0.173 1.8 (0.6–5.5)